naion glp-1 Risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients prescribed semaglutide - Novo Nordisk GLP-1 RAs and NAION: No

One has to ask, why? Hashmi said

The Effects of NLY01, a novel glucagon-like peptide-1 receptor agonist, on cuprizone-induced demyelination and remyelination: challenges and future perspectives

Once you reach your goal, you can: Taper off the medication Move to a lower maintenance dose Stay on temporarily with continued support We help clients transition off GLP-1s while keeping their progress

doi: 10.1017/neu.2020.14

Some experts caution that a clear causal link has not yet been established between the medication and these mental health issues, but in my view whether its causation or correlation doesnt really matter